Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers. Search by keywords: Stay Informed Get the latest information on MSK’s cancer treatments and research sent straight to your inbox with our monthly clinical updates e-newsletter OncoNotes. Newsletter Sign Up Find a Clinical Trial Refer a Patient 232 Clinical Updates found International Clinical Trial Delivers Promising Results of HER2-Targeted Therapy for Non-Small Cell Lung Cancer Saturday, September 18, 2021 By Bob Li, MD, PhD, MPH Including AYA Patients in Cancer Clinical Trials Monday, September 13, 2021 MSK physicians and researchers design and conduct clinical trials that include adolescent and young adult (AYA) cancer patients, ensuring they are not lost between the typical siloes of adult and pediatric cancer trials. When Tailoring Cancer Treatment, Biology Matters More than Age Monday, September 13, 2021 Early-onset colorectal cancer (CRC) is likely clinically and genomically indistinguishable from average-onset cancer, according to a recent study published in the Journal of the National Cancer Institute by MSK investigators. Altered Mental Status in Cancer Patients after COVID-19 Driven by “Cytokine Storm” in CSF Tuesday, March 2, 2021 MSK research team identifies unique markers of inflammation and neurodegeneration found in cerebrospinal fluid of cancer patients with altered mental status after initial SARS-CoV-2 infection, as likely cause of neurologic dysfunction. Minimally Invasive Surgery of Right Superior Liver Segments Safe and Effective Tuesday, March 2, 2021 Minimally invasive surgery (MIS) to resect liver segments 7 and 8 is safe for select patients treated by experienced MIS hepatopancreatobiliary surgeons. Surgical Resection of Benign Spine Tumors Rapidly Improves Patients’ Quality of Life Tuesday, March 2, 2021 Surgical resection of symptomatic, benign intradural extramedullary (IDEM) spine tumors provides rapid, significant, and durable improvements in patient-reported outcomes. Clinical Update Next-generation sequencing "not overhyped": MSK-IMPACT hits 65,000 samples and counting Wednesday, February 24, 2021 At Memorial Sloan Kettering Cancer Center, we have now analyzed more than 50,000 samples in our prospective cohort with MSK-IMPACT™. Breast Conservation Therapy Doesn't Compromise Outcomes in Younger Breast Cancer Patients Thursday, January 14, 2021 Breast conservation therapy as an initial treatment did not compromise survival outcomes compared to mastectomy in breast cancer patients under the age of 35. MSK Kids: Early Immune Cell Reconstitution Predicted Improved Survival Outcomes in Patients with Graft-versus-Host Disease Thursday, January 14, 2021 Early CD4+ T cell reconstitution predicted non-relapsing mortality and overall survival in pediatric patients who received an allogeneic hematopoietic stem cell transplant (HCT) and developed acute graft-versus-host disease. MSK Kids: Retinoblastoma with Choroidal Invasion Successfully Managed with Ophthalmic Artery Chemosurgery, Avoiding Enucleation Thursday, January 14, 2021 Patients with choroidal invasion of retinoblastoma can be successfully managed with ophthalmic artery chemosurgery (OAC) and avoid enucleation. Pagination Load More